Skip to primary navigation
Skip to main content
Skip to footer
Home
LinkedIn
Twitter
About Us
Overview
Executive Committee
Board Of Directors
Partners
Science
Overview
Approach
Technology
shRNA
shARC Platform
Scientific Publications
Pipeline
Newsroom
Press Releases
Events
Media Center
Investors
Overview
Analyst Coverage
Corporate Governance
Regulated Information
Shareholders Information
Shareholders Meeting
Careers
Contact Us
First Half 2022 Financial Results
May 25, 2022
By
Celyad Oncology
Call at 8 a.m. ET / 2 p.m. CET
